Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

December 21, 2015
Otsuka Pharmaceutical

Otsuka Pharmaceutical Concludes Cooperative Agreement to Maintain and Promote Healthy Lifestyles with Shiga Prefecture
December 17, 2015
Taiho Pharmaceutical

Taiho and Meiji Enter Into a Co-marketing Agreement in Japan for TAC-202（bilastine）, a Treatment for Allergic Disorders
December 7, 2015
Otsuka Pharmaceutical

Winner Announced for the 2015 Young Innovator in TB Research Award
December 7, 2015
Otsuka Pharmaceutical

Otsuka Files for Approval in Japan for an Additional Indication for the Antipsychotic ABILIFY: Excitability Associated with Juvenile Autism
December 7, 2015
Otsuka Holdings

OTSUKA FILES FOR APPROVAL IN JAPAN FOR AN ADDITIONAL INDICATION FOR THE ANTIPSYCHOTIC ABILIFY: EXCITABILITY ASSOCIATED WITH JUVENILE AUTISM
December 1, 2015
Otsuka Pharmaceutical

POCARI SWEAT Launched in Cambodia on December 1, 2015
November 26, 2015
Otsuka Pharmaceutical

E Keppra® Injectable, to be Launched in Japan on December 1; Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged 4 and Over with Partial-onset Seizures
November 26, 2015
Taiho Pharmaceutical

NHI Reimbursement Price Listing and Launch of the Novel Antitumor Agent "Yondelis® IV Infusion"
November 17, 2015
Otsuka Pharmaceutical

Otsuka Pharmaceutical Affiliate Avanir Pharmaceuticals Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients with Alzheimer's Disease
November 16, 2015
Otsuka Pharmaceutical

Nature Made Ginkgo Biloba Otsuka Pharmaceutical Introduces Japan's First Food with Specific Function Claim for Cognitive Functions
November 16, 2015
Otsuka Pharmaceutical

10,000 Attend 7th Asan Walking Festival in Itano on November 15 Cosponsored by Otsuka Pharmaceutical Tokushima Itano Factory
November 13, 2015
Taiho Pharmaceutical

Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market TAC-202 (bilastine), an Oral Anti-allergy Drug in Japan
October 7, 2015
Otsuka Pharmaceutical

Acquisition of BIOCENTURY, Leading Spanish Health and Functional Food Company
October 1, 2015
Otsuka Pharmaceutical

New Drug Application for Carteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension
September 28, 2015
Taiho Pharmaceutical

Novel Antitumor Agent "Yondelis® IV Infusion" Approved in Japan for Treatment of Soft Tissue Sarcoma
September 25, 2015
Other

“Lilium® α-200,” a continuous urine volume sensor, will be launched in Japan
September 24, 2015
Taiho Pharmaceutical

Taiho Pharmaceutical Announces FDA Approval of LONSURF® (trifluridine and tipiracil) for Refractory Metastatic Colorectal Cancer (mCRC)
September 16, 2015
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches the antiseptics for external use “Olanedine” on September 16, 2015
September 11, 2015
Otsuka Pharmaceutical

U.S. FDA Accepts First Digital Medicine New Drug Application for Otsuka and Proteus Digital Health
September 3, 2015
Otsuka Pharmaceutical

Three New SOYJOY Bars, Enhanced with More Fruit, More Flavor Raisin, Apple and Hawthorn Berry
September 1, 2015
Taiho Pharmaceutical

The First Pre-Meal Drink in the Solmack Series "Solmack 5 Herbal Digestive Support" Nationwide Launch in Japan on Monday, September 7
August 27, 2015
Otsuka Pharmaceutical

Omugi Gohan Barley Rice from OMUGI SEIKATSU Receive Food with Function Claims Labels specify three benefits, including control of glucose absorption
August 27, 2015
Otsuka Pharmaceutical

Three Nature Made Products Receive Foods with Function Claims Labels specify benefits for eyes and inhibition of triglyceride levels in the blood
August 19, 2015
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory announces changes in the packaging container and volume of Oronine® H Ointment (from now available in an 11-g tube size)
August 13, 2015
Otsuka Pharmaceutical

Otsuka Pharmaceutical's Subsidiary Avanir Pharmaceuticals Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026 in the U.S.
August 6, 2015
Otsuka Pharmaceutical

New Pen-type UL·OS Medicated Skin Whitening Helps Men Avoid Dark Spots and Freckles by Inhibiting Melanin Formation
July 30, 2015
Otsuka Holdings

Notice concerning amendments to the forecasts for the first half of FY2015
July 29, 2015
Otsuka Pharmaceutical

Otsuka Pharmaceutical's Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of Cambridge
July 16, 2015
Otsuka Pharmaceutical

Efficacy Results of Otsuka's Delamanid (Deltyba™) for Extensively Drug-Resistant Tuberculosis (XDR-TB) Published in the New England Journal of Medicine
July 13, 2015
Otsuka Pharmaceutical

U.S. FDA Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia